Crescita Therapeutics (TSE:CTX) Issues Earnings Results

Crescita Therapeutics (TSE:CTX) announced its quarterly earnings data on Monday. The company reported C($0.06) earnings per share for the quarter, FiscalAI reports. Crescita Therapeutics had a negative return on equity of 2.07% and a negative net margin of 1.38%.The firm had revenue of C$5.64 million during the quarter.

Crescita Therapeutics Price Performance

Shares of TSE CTX opened at C$0.76 on Wednesday. Crescita Therapeutics has a twelve month low of C$0.40 and a twelve month high of C$0.76. The firm has a market cap of C$14.15 million, a P/E ratio of 37.50 and a beta of -1.34. The company has a 50 day moving average of C$0.69 and a 200 day moving average of C$0.55. The company has a quick ratio of 2.29, a current ratio of 2.80 and a debt-to-equity ratio of 17.34.

About Crescita Therapeutics

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The firm generates its revenue in the form of product sales and out-licensing revenue.